Abbott Laboratories ABT
NYSE ABT
$109.40 -0.54 (-0.50%)
As of: Nov 9, 2026 · 9:59 AM EST

Abbott Laboratories (ABT) Gains from Sales and Divestitures (2012 - 2017)

Updated

Analysis

Abbott Laboratories (ABT) Gains from Sales and Divestitures (2012 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.81 Bn 235.32 Bn 5.13 Bn
2 Abbott Laboratories 189.40 Bn 163.27 Bn 7.39 Bn
3 Danaher 162.08 Bn 141.74 Bn 3.84 Bn
4 Intuitive Surgical 158.99 Bn 139.28 Bn 2.08 Bn
5 Medtronic 130.53 Bn 95.78 Bn 6.34 Bn
6 Stryker 124.82 Bn 111.01 Bn 4.25 Bn
7 Boston Scientific 62.97 Bn 58.41 Bn 3.43 Bn
8 Edwards Lifesciences 59.51 Bn 42.71 Bn 1.35 Bn
9 Becton Dickinson 58.44 Bn 55.59 Bn 2.32 Bn
10 Agilent Technologies 49.83 Bn 42.72 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 12.00 Mn
Mar 31, 2017 1.15 Bn
Mar 31, 2016 25.00 Mn
Dec 31, 2015 3.00 Mn
Sep 30, 2015 17.00 Mn
Jun 30, 2015 -1.00 Mn
Mar 31, 2015 2.82 Bn
Sep 30, 2013 192.87 Mn
Sep 30, 2012 1.60 Bn
Jun 30, 2012 1.31 Bn
Mar 31, 2012 890.91 Mn
API Access

Abbott Laboratories Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ABT&period=max&api_key=YOUR_API_KEY